LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
74.97 17.25 11 5618 0.0020 -0.0525
MN20160310_N02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
74.97 17.25 12050 5618 2.1446 1.1914
MN20160310_N02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
76.94 17.25 1960 5681 0.3450 0.7610
MN20160310_N02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
76.94 17.25 8489 5681 1.4941 1.0984
MN20160310_N02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
76.94 17.25 282 5681 0.0496 0.3966
MN20160310_N02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
76.94 17.25 9321 5681 1.6405 1.1220
MN20160310_N02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
76.94 17.25 7 5681 0.0012 -0.1022
MN20160310_N02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
76.94 17.25 12141 5681 2.1369 1.1901
MN20160310_N02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
76.94 17.25 6 5681 0.0011 -0.1186
MN20160310_N02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
76.94 17.25 12296 5681 2.1642 1.1934
MN20160310_N02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
78.91 17.25 1529 5730 0.2668 0.7081
MN20160310_N02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
78.91 17.25 8573 5730 1.4960 1.0985
MN20160310_N02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
78.91 17.25 212 5730 0.0370 0.3492
MN20160310_N02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
78.91 17.25 9456 5730 1.6501 1.1232
MN20160310_N02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
78.91 17.25 6 5730 0.0010 -0.1185
MN20160310_N02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
78.91 17.25 12387 5730 2.1616 1.1928
MN20160310_N02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
78.91 17.25 14 5730 0.0024 -0.0246
MN20160310_N02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
78.91 17.25 12569 5730 2.1933 1.1966
MN20160310_N02
H15
MCF 10A-H2B-mCherry Trametinib
0.00021667
80.88 17.25 606 5826 0.1040 0.5276
MN20160310_N02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
80.88 17.25 8592 5826 1.4748 1.0947
MN20160310_N02
D03
MCF 10A-H2B-mCherry Trametinib
0.00021667
80.88 17.25 206 5826 0.0354 0.3435
MN20160310_N02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
80.88 17.25 9653 5826 1.6569 1.1239
MN20160310_N02
D05
MCF 10A-H2B-mCherry Trametinib
0.00021667
80.88 17.25 4 5826 0.0007 -0.1597
MN20160310_N02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
80.88 17.25 12609 5826 2.1642 1.1925
MN20160310_N02
G14
MCF 10A-H2B-mCherry Trametinib
0.00021667
80.88 17.25 3 5826 0.0005 -0.1880
MN20160310_N02
H15